Clarus Therapeutics' Convertible Note Round

Clarus Therapeutics raised a round of funding on June 12, 2014.

Clarus is an emerging men's specialty pharmaceutical company preparing for the commercial launch of REXTORO, an oral testosterone, or T, replacement therapy. On January 3, 2014 the Company submitted a…

Articles about Clarus Therapeutics' Convertible Note Round: